Hepatocellular carcinoma pathogenesis: from genes to environment - PubMed

Affiliations

• PMID: 16929323
• DOI: 10.1038/nrc1934

Review

Hepatocellular carcinoma pathogenesis: from genes to environment

Paraskevi A Farazi et al. Nat Rev Cancer. 2006 Sep.

Abstract

Hepatocellular carcinoma is among the most lethal and prevalent cancers in the human population. Despite its significance, there is only an elemental understanding of the molecular, cellular and environmental mechanisms that drive disease pathogenesis, and there are only limited therapeutic options, many with negligible clinical benefit. This Review summarizes the current state of knowledge of this, the most common and dreaded liver neoplasm, and highlights the principal challenges and scientific opportunities that are relevant to controlling this accelerating global health crisis.

Similar articles

• Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now.

  Bharadwaj M, Roy G, Dutta K, Misbah M, Husain M, Hussain S. Bharadwaj M, et al. Cancer Metastasis Rev. 2013 Jun;32(1-2):229-68. doi: 10.1007/s10555-012-9412-6. Cancer Metastasis Rev. 2013. PMID: 23114844 Review.

• The genetic and environmental basis of hepatocellular carcinoma.

  Farazi PA, DePinho RA. Farazi PA, et al. Discov Med. 2006 Oct;6(35):182-6. Discov Med. 2006. PMID: 17234139 Review.

• Molecular pathogenesis of hepatocellular carcinoma.

  McKillop IH, Moran DM, Jin X, Koniaris LG. McKillop IH, et al. J Surg Res. 2006 Nov;136(1):125-35. doi: 10.1016/j.jss.2006.04.013. Epub 2006 Oct 3. J Surg Res. 2006. PMID: 17023002 Review.

• Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes.

  Bannasch P. Bannasch P. Prog Liver Dis. 1996;14:161-97. Prog Liver Dis. 1996. PMID: 9055578 Review. No abstract available.

• Comparative molecular pathogenesis of hepatocellular carcinomas.

  Hino O, Kitagawa T, Nomura K, Ohtake K, Yasui H, Okamoto N, Hirayama Y. Hino O, et al. Prog Clin Biol Res. 1992;376:173-85. Prog Clin Biol Res. 1992. PMID: 1326769 Review. No abstract available.

Cited by

• Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).

  Zimonjic DB, Popescu NC. Zimonjic DB, et al. Int J Oncol. 2012 Aug;41(2):393-406. doi: 10.3892/ijo.2012.1474. Epub 2012 May 10. Int J Oncol. 2012. PMID: 22580498 Free PMC article. Review.

• Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma.

  Tan C, Liu S, Tan S, Zeng X, Yu H, Li A, Bei C, Qiu X. Tan C, et al. PLoS One. 2015 Mar 4;10(3):e0119210. doi: 10.1371/journal.pone.0119210. eCollection 2015. PLoS One. 2015. PMID: 25739100 Free PMC article.

• DNA damage sensor γ -H2AX is increased in preneoplastic lesions of hepatocellular carcinoma.

  Matsuda Y, Wakai T, Kubota M, Osawa M, Takamura M, Yamagiwa S, Aoyagi Y, Sanpei A, Fujimaki S. Matsuda Y, et al. ScientificWorldJournal. 2013;2013:597095. doi: 10.1155/2013/597095. Epub 2013 Mar 3. ScientificWorldJournal. 2013. PMID: 23533353 Free PMC article.

• Cancer stem cells in the development of liver cancer.

  Yamashita T, Wang XW. Yamashita T, et al. J Clin Invest. 2013 May;123(5):1911-8. doi: 10.1172/JCI66024. Epub 2013 May 1. J Clin Invest. 2013. PMID: 23635789 Free PMC article. Review.

• A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.

  Liu F, Luo L, Wei Y, Wang W, Li B, Yan L, Wen T. Liu F, et al. Tumour Biol. 2013 Feb;34(1):47-53. doi: 10.1007/s13277-012-0509-x. Epub 2012 Sep 13. Tumour Biol. 2013. PMID: 22972504

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information